E Fund Management Co., Ltd. Relay Therapeutics, Inc. Transaction History
E Fund Management Co., Ltd.
- $1.93 Billion
- Q3 2024
A detailed history of E Fund Management Co., Ltd. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 11,550 shares of RLAY stock, worth $55,440. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,550
Previous 11,778
1.94%
Holding current value
$55,440
Previous $76,000
6.58%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RLAY
# of Institutions
203Shares Held
156MCall Options Held
207KPut Options Held
40K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$134 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$69.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$50.6 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.25MShares$44.4 Million5.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.38MShares$35.4 Million0.88% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $577M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...